Apparent Behavioral Benefits of Tau Overexpression in P301L Tau Transgenic Mice

被引:1
作者
Morgan, Dave [1 ]
Munireddy, Sanjay [1 ]
Alamed, Jennifer [1 ]
DeLeon, Jason [1 ]
Diamond, David M. [2 ,3 ,4 ,8 ]
Bickford, Paula [5 ,6 ,8 ]
Hutton, Michael [7 ]
Lewis, Jada [7 ]
McGowan, Eileen [7 ]
Gordon, Marcia N. [1 ]
机构
[1] Univ S Florida, Alzheimer Res Lab, Dept Pharmacol, Tampa, FL 33612 USA
[2] Univ S Florida, Dept Psychol, Tampa, FL 33612 USA
[3] Univ S Florida, Dept Mol Pharmacol, Tampa, FL 33612 USA
[4] Univ S Florida, Ctr Preclin & Clin Res PTSD, Tampa, FL 33612 USA
[5] Univ S Florida, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA
[6] Univ S Florida, Dept Neurosurg, Tampa, FL 33612 USA
[7] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA
[8] James A Haley Vet Adm Med Ctr, Tampa, FL 33612 USA
基金
美国国家卫生研究院;
关键词
Amyloid; rotarod; tau; transgenic mice; water maze; Y-maze;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Transgenic mice expressing human tau containing the P301L tau mutation (JNPL3; tau mice) develop motor neuron loss, paralysis and death between 7 and 12 months. Surprisingly, at 5 and 7 months of age, tau transgenic mice were superior to other genotypes in the rotarod task, and had near perfect scores on the balance beam and coat hanger tests. One tau transgenic mouse was performing at a superior level in the rotarod one day prior to developing paralysis. Cognitive function was also normal in the tau mice evaluated in the radial arm water maze and the Y-maze tasks. We also crossed the tau transgenic mice with Tg2576 amyloid-beta protein precursor (A beta PP) transgenic mice. Although A beta PP mice were deficient in the radial arm maze task, A beta PP + tau mice were not impaired, implying a benefit of the tau transgene. Some mice were homozygous for the retinal degeneration mutation (rd/rd) and excluded from the genotype analysis. Only the water maze task discriminated the rd/rd mice from nontransgenic mice. In conclusion, it seems that the modest tau overexpression or the presence of mutant tau in the JNPL3 tau mice may provide some benefit with respect to motor and cognitive performance before the onset of paralysis.
引用
收藏
页码:605 / 614
页数:10
相关论文
共 50 条
  • [31] Effect size of memory deficits in mice with adult-onset P301L tau expression
    Hunsberger, Holly C.
    Rudy, Carolyn C.
    Weitzner, Daniel S.
    Zhang, Chong
    Tosto, David E.
    Knowlan, Kevin
    Xu, Ying
    Reed, Miranda N.
    BEHAVIOURAL BRAIN RESEARCH, 2014, 272 : 181 - 195
  • [32] P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway
    Hunsberger, Holly C.
    Rudy, Carolyn C.
    Batten, Seth R.
    Gerhardt, Greg A.
    Reed, Miranda N.
    JOURNAL OF NEUROCHEMISTRY, 2015, 132 (02) : 169 - 182
  • [33] Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice
    Xu, Jiqing
    Sato, Shinji
    Okuyama, Satoshi
    Swan, Russell J.
    Jacobsen, Michael T.
    Strunk, Elena
    Ikezu, Tsuneya
    FASEB JOURNAL, 2010, 24 (08) : 2904 - 2915
  • [34] T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice
    Fukushima, Tetsuo
    Nakamura, Asako
    Iwakami, Noboru
    Nakada, Yasushi
    Hattori, Hiroshi
    Hoki, Satoru
    Yamaguchi, Hidetoshi
    Nakagawa, Masaya
    Terashima, Nobuo
    Narita, Hirokazu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 407 (04) : 730 - 734
  • [35] Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease
    Bennett, Rachel E.
    Robbins, Ashley B.
    Hu, Miwei
    Cao, Xinrui
    Betensky, Rebecca A.
    Clark, Tim
    Das, Sudeshna
    Hyman, Bradley T.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (06) : E1289 - E1298
  • [36] Microglial activation in brain lesions with tau deposits:: Comparison of human tauopathies and tau transgenic mice TgTauP301L
    Sasaki, Atsushi
    Kawarabayashi, Takeshi
    Murakami, Tetsuro
    Matsubara, Etsuro
    Ikeda, Masaki
    Hagiwara, Haruo
    Westaway, David
    George-Hyslop, Peter S.
    Shoji, Mikio
    Nakazato, Yoichi
    BRAIN RESEARCH, 2008, 1214 : 159 - 168
  • [37] The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer's disease
    Jimenez, Heidy
    Adrien, Leslie
    Wolin, Adam
    Eun, John
    Chang, Eric H. H.
    Burstein, Ethan S. S.
    Gomar, Jesus
    Davies, Peter
    Koppel, Jeremy
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
  • [38] P301L tau mutation leads to alterations of cell cycle, DNA damage response and apoptosis: Evidence for a role of tau in cancer
    Cimini, Sara
    Giaccone, Giorgio
    Tagliavini, Fabrizio
    Costantino, Matteo
    Perego, Paola
    Rossi, Giacomina
    BIOCHEMICAL PHARMACOLOGY, 2022, 200
  • [39] Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines
    Xia, Di
    Li, Chuanzhou
    Goetz, Juergen
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (05): : 913 - 924
  • [40] Early behavioural markers of disease in P301S tau transgenic mice
    Scattoni, Maria Luisa
    Gasparini, Laura
    Alleva, Enrico
    Goedert, Michel
    Calamandrei, Gemma
    Spillantini, Maria Grazia
    BEHAVIOURAL BRAIN RESEARCH, 2010, 208 (01) : 250 - 257